At its upcoming March 29th hearing session in San Diego, the United States Judicial Panel on Multidistrict Litigation will consider two separate petitions for the centralization of dangerous drug lawsuits against Propecia and Zoloft.
The petition regarding Propecia was filed by plaintiff Christopher Masefield and asks for the centralization of almost a dozen federal lawsuits involving the hair loss drug. Merck, the maker of the drug, has been the subject of lawsuits in various federal districts that allege the drug failed to adequately warn of possibly irreversible male sexual dysfunction, clinical depression, and male breast cancer that the drug may cause.
The Panel will also consider a petition regarding the coordination of lawsuits being levied against Pfizers antidepressant drug Zoloft. The petition asks for a number of pending federal lawsuits involving birth injuries allegedly caused by the antidepressant drug to be transferred to the Southern District of New York, where the pharma company is based.
In addition to being linked to birth defects, Zoloft has also been linked to anxiety, panic attacks, depression, and suicidal thoughts in some users.
If you or a loved one have been harmed by a dangerous drug such as Propecia or Zoloft, call Sokolove Law today to learn more about possibly pursing a lawsuit against the companies that manufacture them.